March 2, 2017
Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies.
Coverge from Ludwig Cancer Research here.
Cancer Discovery publication here.